Drug Database
PR

propafenone hydrochloride (propafenone, SR / propafenone SR / Rythmol SR)

✓ Approved

GSK · SCN5A · 小分子

什么是 propafenone hydrochloride?

propafenone hydrochloride 是一种小分子,由GSK研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

商品名propafenone, SR, propafenone SR, Rythmol SR
公司GSK
药物类别小分子
分子靶点SCN5A
给药途径Oral (PO)
状态Approved

作用机制

分子靶点

propafenone hydrochloride 作用于 1 个分子靶点:

SCN5Asodium voltage-gated channel alpha subunit 5 (CMD1E, SSS1)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

propafenone hydrochloride 针对 2 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Cardiac disordersAtrial fibrillation✓ Approved
Cardiac disordersVentricular fibrillation✓ Approved

相关研究文献

PubMedbioRxiv : the preprint server for biology2026-11-20

Differential regulation of myeloid Scavenger Receptor A (CD204) expression in humans versus mice in response to sepsis.

Ozment Tammy R TR, McGlothlin Melanie D MD, Adkins James J, Hopkins Nikolas N et al.

Sepsis is the number one cause of mortality in the critically ill patient. The underlying pathophysiology of sepsis is not fully understood. Scavenger Receptor A (SR-A) is a promiscuous receptor of myeloid cells that binds multiple pathogen associated molecular patterns (PAMPs). We have demonstrated that SR-A promotes mortality in murine sepsis. The present study sought to examine the effect of sepsis on myeloid SR-A expression in septic mice and compare it to sepsis patients. Leukocytes were isolated from mice after cecal ligation and puncture. Blood leukocytes were isolated from sepsis patients. Myeloid cells were isolated from healthy mice or human subjects and were treated with PAMPs. Leukocyte phenotype and SR-A expression were determined by flow cytometry. CLP increased SR-A expression when compared to sham operated animals on both neutrophils and monocytes/macrophages. In contrast, SR-A expression was not changed on either neutrophils or monocytes from sepsis patients when compared to healthy control subjects. Treatment of murine neutrophils and macrophages with Pam3CSK4 and treatment of macrophages with LPS increased SR-A expression. Human neutrophil SR-A expression was not altered by any PAMPs, and only treatment with C. albicans glucan increased SR-A expression on human monocytes. Myeloid SR-A expression is increased in septic mice, and this increase plays a detrimental role in the response to sepsis, while SR-A expression is not changed in leukocytes from septic patients and does not correlate with SOFA II scores. Thus, myeloid SR-A expression does not appear to play significant a role in the pathophysiology of human sepsis. SR-A (CD204) is differentially regulated in mouse versus human sepsis.

PMID 43060121
阅读全文 →
PubMediScience2026-11-20

Centrosome depletion reprograms RNA splicing to promote neuroblastoma differentiation through SR factor dephosphorylation.

Cipolletta Giampiero G, Faretra Luca L, Puopolo Giovanni G, Mellone Agostino A et al.

Centrosomes are key regulators of cell division and may also contribute to cell fate determination. By combining immunoprecipitation with spatial immunofluorescence in neuroblastoma stem cells, we found that U2 and U5 small nuclear RNAs (snRNAs) preferentially associate with centrosomal subdistal appendages (sDAPs), mirroring the localization of the SR splicing factor SRSF2. Retinoic acid (RA)-induced neuronal differentiation was accompanied by coordinated changes in centrosome expression and pre-mRNA splicing. Notably, PLK4 inhibition-induced centriolar loss prior to RA treatment enhanced neuronal maturation. Centrosome depletion was further associated with increased intron retention and dephosphorylation of SR splicing factors, including SRSF2, at the centrosome. Analysis of a retained intron in the centrosome-associated WDR13 transcript identified two 3' splice acceptor sites whose usage was reduced following centrosome depletion. Together, these findings reveal that centrosome loss reprograms RNA splicing to promote neuroblastoma differentiation, revealing a potential strategy for programmable control of cell fate.

PMID 43061371
阅读全文 →
PubMedJournal of global health2026-11-20

Erratum: Julian GS, Spinardi JR, Flora AP, Valluri SR, d'Hellencourt FL, Liang C, Begier E, Berra TZ, Cortez LV, Vitorasso R, Kyaw MH. Seasonal dynamics and burden of respiratory syncytial virus, influenza, and COVID-19 in Brazil: a national surveillance study (2019-2023). J Glob Health. 2026;16:04251.

Journal of Global Health Editorial Team

PMID 43061885
阅读全文 →
PubMedGenome medicine2026-11-20

Evaluating long-read RNA sequencing for Mendelian disorder diagnosis.

Hou Huayun H, Liang Yijing Y, Pipko Neta N, Tsoi Chung Ting CT et al.

RNA sequencing (RNA-seq) is a valuable tool for variant interpretation and diagnosis of rare Mendelian disorders. However, the inability of standard short-read (SR) sequencing to resolve complex transcriptional changes restricts its full diagnostic potential. Long-read (LR) sequencing technologies overcome these constraints by sequencing full-length cDNA, though their diagnostic efficiency remains to be assessed. We performed LR RNA-seq using the PacBio Kinnex method in clinically accessible sample types (whole blood, fibroblasts, and lymphoblastoid cell lines (LCLs)) from 50 individuals with paired SR RNA-seq, including a n = 24 "control cohort", previously diagnosed individuals with pathogenic mRNA aberrations, and a n = 26 "discovery cohort", undiagnosed individuals with candidate DNA variants suitable for interrogation by RNA-seq. We generate reference data sets, perform key bench-marking analyses and develop a novel bioinformatics and analytical pipeline to capture pathogenic transcriptional changes, including splicing changes, gene expression changes, differential isoform usage, allelic biases, gene fusions, and structural variants. We go on to find that LR RNA-seq results in a streamlined analysis output and that it provides improved resolution and mechanistic insights compared with SR RNA-seq in over half of our cases with positive RNA findings (57% control cohort, 80% discovery cohort). We identify key advantages of the isoform-level resolution provided by LR RNA-seq including direct phasing of variant​ consequences, clarification of splice junction boundaries, differential isoform usage analysis, identification of novel transcriptional events, and characterization of the consequences of structural variants and gene fusions. A highlight of these findings includes the first report of autosomal recessive Cleidocranial Dysplasia. Despite many advantages, we also identify and highlight critical limitations of LR RNA-seq including poor capture of short isoforms and uneven coverage in specific long transcripts. Altogether, we find that LR RNA-seq streamlines transcriptome analysis in complex scenarios. Our study provides important insights into the clinical application of this novel technology.

PMID 43058889
阅读全文 →
PubMedbioRxiv : the preprint server for biology2026-11-20

RyR2-Mediated Ca 2+ Leak Drives Progressive Arrhythmogenic Cardiomyopathy.

Zheng Jingjing J, Ponce-Balbuena Daniela D, Estrada Sergio S, Xiao Li L et al.

Abnormal sarcoplasmic reticulum (SR) Ca 2+ release through ryanodine receptor 2 (RyR2) is a well-established mechanism of ventricular arrhythmias. Whether persistent RyR2 dysfunction can also initiate the structural remodeling characteristic of arrhythmogenic cardiomyopathy (ACM) remains unknown. We tested the hypothesis that chronic RyR2-mediated Ca 2+ leak is sufficient to couple electrical instability to progressive cardiomyopathy. We generated a rabbit carrying the severe gain-of-function RyR2-V2475F mutation and characterized disease progression using longitudinal cardiac phenotyping, continuous electrocardiographic monitoring, cellular electrophysiology and Ca 2+ imaging, histopathology, biochemical analyses, and single-nucleus RNA sequencing (snRNA-seq). Therapeutic potential was evaluated by continuous treatment with the selective RyR2 inhibitor ent -verticilide for two months. RyR2-V2475F rabbits developed spontaneous ventricular tachyarrhythmias, sudden cardiac death, and progressive right ventricular (RV)-dominant fibrofatty cardiomyopathy recapitulating major features of human ACM. Malignant ventricular arrhythmias preceded overt structural remodeling and were associated at the cellular level with early spontaneous Ca 2+ release and early afterdepolarizations. Early disease was characterized by remodeling of excitation-contraction coupling with preserved SR Ca 2+ load and contractile function despite RyR2 dysfunction; upon disease progression, these compensatory changes were accompanied by SR Ca 2+ depletion, impaired RV contractility and reduced left ventricular filling. Single-nucleus transcriptomics identified early fibroblast expansion and predicted cardiomyocyte-centered paracrine signaling before advanced fibrofatty infiltration. Cardiomyocytes also exhibited an altered lipid-metabolic transcriptome and intracellular lipid accumulation, accompanied by enhanced mitochondrial Ca 2+ uptake. Selective RyR2 inhibition markedly reduced ventricular tachycardia burden and preserved RV contraction and LV filling during disease progression. Severe RyR2 gain-of-function can lead to both malignant ventricular arrhythmias and progressive arrhythmogenic cardiomyopathy in a large-animal model, establishing persistent intracellular Ca 2+ dysregulation as a mechanistic link between electrical and structural heart disease. The ability of selective RyR2 inhibition to suppress arrhythmias and preserve cardiac function identifies RyR2 as a potentially actionable therapeutic target in arrhythmogenic cardiomyopathy.

PMID 43060124
阅读全文 →
PubMedResearch square2026-11-20

Molecular basis for allosteric regulation of RyR1 channel gating: effects of a therapeutic drug and oxidation-mimicking mutation.

Sanbonmatsu Karissa K, Prajapati Jigneshkumar J, Miotto Marco M, Gc Jeevan J et al.

RyR1, an enormous, approximately 2.2 MDa, tetrameric calcium-release channel in the sarcoplasmic reticulum (SR) of skeletal muscle, is essential for excitation-contraction coupling. Pathogenic mutations in RyR1 cause RyR1-related myopathies. ARM210 (S48168), a Rycal-class drug, has shown promise in treating RyR1-related myopathies in a recently concluded phase 1b clinical trial. Structural studies revealed that ARM210 binds to the peripheral RY1&2 domain of RyR1, stabilizing it in a closed state to prevent aberrant SR Ca 2+ leak. Here, we investigate ARM210's mechanism of action at the atomistic level using extensive all-atom (~2.5 million atoms) explicit-solvent molecular dynamics simulations totaling 36.6 μs. Simulations revealed a long-range allosteric pathway in the wild-type RyR1 that propagates over 200 Å, linking the RY1&2 domain to the pore-forming S6 helices of adjacent protomers and enabling pore opening. Subsequently, we demonstrated that ARM210 binding stabilizes the RY1&2 domain in a closed conformation, rigidifying the cytosolic shell and activation core and disrupting the allosteric network necessary for pore dilation. These findings describe a plausible mode of action for how ARM210 stabilizes RyR1 in a closed state by modulating long-range allostery. Furthermore, we show that this allosteric regulatory network is perturbed by the oxidative stress-mimicking C3892D mutation near the Ca 2+ activator site, identified via mass spectrometry, live-cell fluorescence microscopy, and electrophysiology.

PMID 43060363
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多propafenone hydrochloride